149 related articles for article (PubMed ID: 12581321)
1. Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipients.
Silverstein DM
Pediatr Transplant; 2003 Feb; 7(1):7-10. PubMed ID: 12581321
[No Abstract] [Full Text] [Related]
2. Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients.
Argent E; Kainer G; Aitken M; Rosenberg AR; Mackie FE
Pediatr Transplant; 2003 Feb; 7(1):38-42. PubMed ID: 12581326
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin: a new agent for hyperlipidemia.
Kupecz D
Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
[No Abstract] [Full Text] [Related]
4. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency.
Hegele RA; Little JA; Connelly PW
Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500
[No Abstract] [Full Text] [Related]
5. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
[TBL] [Abstract][Full Text] [Related]
6. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
Singhal MK; Bhaskaran S; Szabo T; La Rosa R
Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354
[No Abstract] [Full Text] [Related]
7. Variable influence of statins on isoprostanes in hyperlipidemia.
Sinzinger H; Oguogho A
Adv Exp Med Biol; 2003; 525():209-12. PubMed ID: 12751770
[No Abstract] [Full Text] [Related]
8. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
Liguori E; Sarcinella R
Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
[No Abstract] [Full Text] [Related]
9. Routine statin treatment after acute coronary syndromes?
Acevedo M; Sprecher DL; Lauer MS; Francis G
Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
[No Abstract] [Full Text] [Related]
10. Atorvastatin for acute coronary syndromes.
Wierzbicki AS; Mikhaildis DP; Reynolds TR
JAMA; 2001 Aug; 286(5):532-3; author reply 533-5. PubMed ID: 11476649
[No Abstract] [Full Text] [Related]
11. Atorvastatin for acute coronary syndromes.
Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
[No Abstract] [Full Text] [Related]
12. High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia.
Wierzbicki AS; Lumb PJ; Chik G; Crook MA
Am J Cardiol; 2000 Sep; 86(5):547-9, A9. PubMed ID: 11009276
[TBL] [Abstract][Full Text] [Related]
13. More on switching statins: comments from Pfizer.
Lloyd K
BMJ; 2006 Sep; 333(7569):655; author reply 655-6. PubMed ID: 16990337
[No Abstract] [Full Text] [Related]
14. A statin for a patient with hyperlipidemia and hepatitis C?
Nash DT
Postgrad Med; 2004 May; 115(5):86. PubMed ID: 15171081
[No Abstract] [Full Text] [Related]
15. The nature of the statins.
Jones PH
Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539
[No Abstract] [Full Text] [Related]
16. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group.
McKenney JM; McCormick LS; Weiss S; Koren M; Kafonek S; Black DM
Am J Med; 1998 Feb; 104(2):137-43. PubMed ID: 9528731
[TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering therapy in acute coronary syndromes.
Sacks FM
JAMA; 2001 Apr; 285(13):1758-60. PubMed ID: 11277832
[No Abstract] [Full Text] [Related]
18. ASCOT-LLA: questions about the benefits of atorvastatin.
Ravnskov U
Lancet; 2003 Jun; 361(9373):1986; author reply 1986-7. PubMed ID: 12801761
[No Abstract] [Full Text] [Related]
19. Reducing residual risk in secondary prevention of cardiovascular disease.
Stone NJ
Circulation; 2012 Apr; 125(16):1958-60. PubMed ID: 22461417
[No Abstract] [Full Text] [Related]
20. Re: Gómez-Gerique, et al. Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis 2002;162:245-51.
Moriarty PM; Backes JM
Atherosclerosis; 2003 Jan; 166(1):201. PubMed ID: 12564455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
